Treatment algorithm

Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer

ACUTE

neonates: nonbullous impetigo

Back
1st line – 

oral antibiotics plus skin hygiene

Undertake antibiotic treatment in neonates in collaboration with a pediatric dermatologist or infectious disease specialist.

Patients in the first month of life presenting with nonbullous impetigo require oral antibiotics.

Erythromycin is the initial choice. Treatment course is 7 days.

Intranasal antibiotics are generally not used in neonates.

In addition to the antibiotic treatment, twice-daily washing with soap and water is good general skin care for all patients with impetigo, as it helps reduce the amount of bacteria on the skin. This washing routine may also be recommended for close patient contacts who may have acquired the bacteria. Chlorhexidine is not recommended in neonates (due to issues related to its potential toxicity with absorption).

Primary options

erythromycin base: consult specialist for guidance on neonatal doses

Secondary options

clindamycin: consult specialist for guidance on neonatal doses

Back
1st line – 

parenteral vancomycin plus skin hygiene

Undertake antibiotic treatment in neonates in collaboration with a pediatric dermatologist or infectious disease specialist.

Vancomycin is recommended if MRSA is suspected (cases of spontaneous abscess or cellulitis; lesions that do not resolve with recommended antibiotic treatment) and/or determined by antibiotic susceptibility testing. Treatment course is usually 7 to 10 days.

Intranasal antibiotics are generally not used in neonates.

In addition to the antibiotic treatment, twice-daily washing with soap and water is good general skin care for all patients with impetigo, as it helps reduce the amount of bacteria on the skin. This washing routine may also be recommended for close patient contacts who may have acquired the bacteria. Chlorhexidine is not recommended in neonates (due to issues related to its potential toxicity with absorption).

Primary options

vancomycin: consult specialist for guidance on neonatal doses

neonates: bullous impetigo

Back
1st line – 

parenteral antibiotics plus skin hygiene

Undertake antibiotic treatment in neonates in collaboration with a pediatric dermatologist or infectious disease specialist.

If antibiotic susceptibility testing indicates MRSA, vancomycin is recommended. Treatment course is usually 7 to 10 days.

Intranasal antibiotics are generally not used in neonates.

In addition to the antibiotic treatment, twice-daily washing with soap and water is good general skin care for all patients with impetigo, as it helps reduce the amount of bacteria on the skin. This washing routine may also be recommended for close patient contacts who may have acquired the bacteria. Chlorhexidine is not recommended in neonates (due to issues related to its potential toxicity with absorption).

Primary options

clindamycin: consult specialist for guidance on neonatal doses

OR

nafcillin: consult specialist for guidance on neonatal doses

OR

oxacillin: consult specialist for guidance on neonatal doses

Back
1st line – 

parenteral vancomycin plus skin hygiene

Undertake antibiotic treatment in neonates in collaboration with a pediatric dermatologist or infectious disease specialist.

Vancomycin is recommended if MRSA is suspected (cases of spontaneous abscess or cellulitis; lesions that do not resolve with recommended antibiotic treatment) and/or determined by antibiotic susceptibility testing. Treatment course is usually 7 to 10 days.

Intranasal antibiotics are generally not used in neonates.

In addition to the antibiotic treatment, twice-daily washing with soap and water is good general skin care for all patients with impetigo, as it helps reduce the amount of bacteria on the skin. This washing routine may also be recommended for close patient contacts who may have acquired the bacteria. Chlorhexidine is not recommended in neonates (due to issues related to its potential toxicity with absorption).

Primary options

vancomycin: consult specialist for guidance on neonatal doses

adults, children, and infants: superficial or limited infection

Back
1st line – 

topical antibiotics plus skin hygiene

These patients have no evidence of deeper soft tissue involvement (abscess, cellulitis) or hematogenous spread (fever, constitutional symptoms).

Topical antibiotics such as mupirocin, retapamulin, and ozenoxacin are the first-line treatment options, except where resistance is evident.[25][28][29]​​​​​[31][32][33]​ There is no difference in effectiveness between topical antibiotics. Evidence indicates that topical medications are equally or more effective than oral antibiotics for limited disease.[28]​ Treatment course is usually 5 to 7 days. If retapamulin or ozenoxacin are used, total treatment area should not exceed 100 cm² total body surface area in adults, and 2% of total body surface area in children (9 months or older for retapamulin; 2 months or older for ozenoxacin).[1][33][37]​​​

In addition to topical antibiotic treatment, twice-daily washing with soap and water is good general skin care for all patients with impetigo, as it helps reduce the amount of bacteria on the skin. For older children and adults, particularly those with more widespread skin involvement, chlorhexidine can be a good antibacterial cleanser to add to the routine.[36]​ Chlorhexidine is not recommended in children younger than 4 years (due to issues related to its potential toxicity with absorption). This washing routine may also be recommended for close patient contacts who may have acquired the bacteria.

Primary options

mupirocin topical: (2%) apply to affected skin and nares three times daily

OR

retapamulin topical: (1%) apply to affected skin twice daily for 5 days

OR

ozenoxacin topical: (1%) apply to affected skin twice daily for 5 days

Back
Plus – 

intranasal antibiotics

Treatment recommended for ALL patients in selected patient group

Intranasal antibiotic (applied to the nares at the same frequency as antibiotic skin application for 5 to 7 days of the month) is additionally used for patients who experience frequent recurrences of their impetigo.[36]​ If several family members other than the patient are affected by impetigo, intranasal antibiotic alone would be prescribed for the unaffected individual(s). In either case, the intention is to decrease nasal colonization by bacteria. The nasal reservoir can serve as a source for reinfection of an individual or spread of the infection to close contacts.

Primary options

mupirocin topical: (2%) apply to affected nares three times daily for 7 days

adults, children, and infants: widespread cutaneous lesions

Back
1st line – 

oral antibiotics plus skin hygiene

These patients have no evidence of deeper soft tissue involvement (abscess, cellulitis) or hematogenous spread (fever, constitutional symptoms).

Oral antibiotics including dicloxacillin, erythromycin, or a first-generation cephalosporin (e.g., cephalexin) are the recommended agents for these patients. Treatment course is usually 7 days.

Immunocompromised patients are at greater risk for developing a complicated course of infection; parenteral antibiotic treatment is a consideration for patients with widespread lesions and severe immune compromise.[28][30]

In addition to topical antibiotic treatment, twice-daily washing with soap and water is good general skin care for all patients with impetigo, as it helps reduce the amount of bacteria on the skin. For older children and adults, particularly those with more widespread skin involvement, chlorhexidine can be a good antibacterial cleanser to add to the routine.[36]​ Chlorhexidine is not recommended in young children (due to issues related to its potential toxicity with absorption). This washing routine may also be recommended for close patient contacts who may have acquired the bacteria.

Primary options

dicloxacillin: children: 25-50 mg/kg/day orally given in divided doses every 6 hours; adults: 250 mg orally every 6 hours

OR

erythromycin base: children: 40 mg/kg/day orally given in divided doses every 6 hours; adults: 250 mg orally every 6 hours

OR

cephalexin: children: 25-50 mg/kg/day orally given in divided doses every 6 hours; adults: 250-500 mg orally every 6 hours

Back
Consider – 

intranasal antibiotics

Treatment recommended for SOME patients in selected patient group

Intranasal antibiotic (applied to the nares at the same frequency as antibiotic skin application for 5 to 7 days of the month) is additionally used for patients who experience frequent recurrences of their impetigo.[36]​ If several family members other than the patient are affected by impetigo, intranasal antibiotic alone would be prescribed for the unaffected individual(s). In either case, the intention is to decrease nasal colonization by bacteria. The nasal reservoir can serve as a source for reinfection of an individual or spread of the infection to close contacts.

Primary options

mupirocin topical: (2%) apply to affected nares three times daily for 7 days

Back
1st line – 

oral antibiotics plus skin hygiene

These patients have no evidence of deeper soft tissue involvement (abscess, cellulitis) or hematogenous spread (fever, constitutional symptoms).

If MRSA is suspected (cases of spontaneous abscess or cellulitis; lesions that do not resolve with recommended antibiotic treatment) and/or determined by antibiotic susceptibility testing, appropriate antibiotic choices include clindamycin, trimethoprim/sulfamethoxazole, or doxycycline. Treatment course is usually 7 days.

In addition to topical antibiotic treatment, twice-daily washing with soap and water is good general skin care for all patients with impetigo, as it helps reduce the amount of bacteria on the skin. For older children and adults, particularly those with more widespread skin involvement, chlorhexidine can be a good antibacterial cleanser to add to the routine.[36]​ Chlorhexidine is not recommended in young children (due to issues related to its potential toxicity with absorption). This washing routine may also be recommended for close patient contacts who may have acquired the bacteria.

Primary options

clindamycin: children: 10-30 mg/kg/day orally given in divided doses every 6-8 hours; adults: 150-450 mg orally every 6-8 hours

OR

sulfamethoxazole/trimethoprim: children: 8-10 mg/kg/day orally given in divided doses every 12 hours; adults: 160 mg orally every 12 hours

More

Secondary options

doxycycline: children: 2.2 to 4.4 mg/kg/day orally given in divided doses every 12 hours; adults: 50-100 mg orally twice daily

More
Back
Consider – 

intranasal antibiotics

Treatment recommended for SOME patients in selected patient group

Intranasal antibiotic (applied to the nares at the same frequency as antibiotic skin application for 5 to 7 days of the month) is additionally used for patients who experience frequent recurrences of their impetigo. If several family members other than the patient are affected by impetigo, intranasal antibiotic alone would be prescribed for the unaffected individual(s). In either case, the intention is to decrease nasal colonization by bacteria. The nasal reservoir can serve as a source for reinfection of an individual or spread of the infection to close contacts.

Primary options

mupirocin topical: (2%) apply to affected nares three times daily for 7 days

adults, children, and infants: deep soft tissue infection or hematogenous spread

Back
1st line – 

parenteral antibiotics plus skin hygiene

Patients with evidence of soft tissue infection (abscess, cellulitis) or hematogenous spread (fever, constitutional symptoms) will require treatment with parenteral antibiotics.

Clindamycin, nafcillin, and oxacillin are all considered first-line options. Treatment course is usually 10 to 14 days. If the patient has positive blood cultures, reevaluate the status of blood cultures prior to discontinuation of parenteral treatment.

Collaboration with an infectious disease specialist (pediatric or adult) is a consideration when treating infants, children, immunocompromised patients, or any patient poorly responsive to initial parenteral antibiotic treatment.

In addition to the antibiotic treatment, twice-daily washing with soap and water is good general skin care for all patients with impetigo, as it helps reduce the amount of bacteria on the skin. For older children and adults, particularly those with more widespread skin involvement, chlorhexidine can be a good antibacterial cleanser to add to the routine.[36]​ Chlorhexidine is not recommended in young children (due to issues related to its potential toxicity with absorption). This washing routine may also be recommended for close patient contacts who may have acquired the bacteria.

Primary options

clindamycin: children: 25-40 mg/kg/day intravenously/intramuscularly given in divided doses every 6-8 hours; adults: 150-450 mg intravenously/intramuscularly every 6-8 hours

OR

nafcillin: children: 100-200 mg/kg/day intravenously/intramuscularly given in divided doses every 4-6 hours; adults: 500-2000 mg intravenously every 4-6 hours, or 500 mg intramuscularly every 4-6 hours

OR

oxacillin: children: 100-200 mg/kg/day intravenously/intramuscularly given in divided doses every 4-6 hours; adults: 500-2000 mg intravenously/intramuscularly every 4-6 hours

Back
Consider – 

intranasal antibiotics

Treatment recommended for SOME patients in selected patient group

Intranasal antibiotic (applied to the nares at the same frequency as antibiotic skin application for 5 to 7 days of the month) is additionally used for patients who experience frequent recurrences of their impetigo. If several family members other than the patient are affected by impetigo, intranasal antibiotic alone would be prescribed for the unaffected individual(s). In either case, the intention is to decrease nasal colonization by bacteria. The nasal reservoir can serve as a source for reinfection of an individual or spread of the infection to close contacts.

Primary options

mupirocin topical: (2%) apply to affected nares three times daily for 7 days

Back
1st line – 

parenteral antibiotics plus skin hygiene

Patients with evidence of soft tissue infection (abscess, cellulitis) or hematogenous spread (fever, constitutional symptoms) will require treatment with parenteral antibiotics.

Vancomycin is recommended if MRSA is suspected (cases of spontaneous abscess or cellulitis; lesions that do not resolve with recommended antibiotic treatment) and/or determined by antibiotic susceptibility testing. Treatment course is usually 10 to 14 days. If the patient has positive blood cultures, re-evaluate the status of blood cultures prior to discontinuation of parenteral treatment.

Collaboration with an infectious disease specialist (pediatric or adult) is a consideration for infants, children, immunocompromised patients, or any patient poorly responsive to initial parenteral antibiotic treatment.

When alternatives to vancomycin are required, oritavancin, dalbavancin, and tedizolid can be considered in patients with complicated impetigo who require parenteral therapy.

In addition to the antibiotic treatment, twice-daily washing with soap and water is good general skin care for all patients with impetigo, as it helps reduce the amount of bacteria on the skin. For older children and adults, particularly those with more widespread skin involvement, chlorhexidine can be a good antibacterial cleanser to add to the routine.[36]​ Chlorhexidine is not recommended in young children (due to issues related to its potential toxicity with absorption). This washing routine may also be recommended for close patient contacts who may have acquired the bacteria.

Primary options

vancomycin: children: 40 mg/kg/day intravenously given in divided doses every 6-8 hours for 10-14 days; adults: 500 mg intravenously every 6 hours, or 1000 mg intravenously every 12 hours for 10-14 days

Secondary options

oritavancin: adults: 1200 mg intravenously as a single dose

OR

dalbavancin: adults: 1500 mg intravenously as a single dose, or 1000 mg intravenously as a single dose followed by 500 mg 1 week later

OR

tedizolid phosphate: adults: 200 mg intravenously once daily for 6 days

Back
Consider – 

intranasal antibiotics

Treatment recommended for SOME patients in selected patient group

Intranasal antibiotic (applied to the nares at the same frequency as antibiotic skin application for 5 to 7 days of the month) is additionally used for patients who experience frequent recurrences of their impetigo. If several family members other than the patient are affected by impetigo, intranasal antibiotic alone would be prescribed for the unaffected individual(s). In either case, the intention is to decrease nasal colonization by bacteria. The nasal reservoir can serve as a source for reinfection of an individual or spread of the infection to close contacts.

Primary options

mupirocin topical: (2%) apply to affected nares three times daily for 7 days

back arrow

Choose a patient group to see our recommendations

Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer

Use of this content is subject to our disclaimer